Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscleInvasive Bladder Cancer Treated with Bacillus CalmetteGuérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596

被引：0

作者：

Contieri, Roberto ^{[1
,2
]}

Hensley, Patrick J. ^{[3
]}

Kamat, Ashish M. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA

[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[3] Univ Kentucky, Coll Med, Dept Urol, Lexington, KY USA

来源：

EUROPEAN UROLOGY ONCOLOGY | 2024年 / 7卷 / 02期

关键词：

D O I：

10.1016/j.euo.2023.09.018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：301 / 301

页数：1

共 3 条

[1] Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscleInvasive Bladder Cancer Treated with Bacillus CalmetteGuérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596
Montorsi, Francesco
Rosiello, Giuseppe
Gandaglia, Giorgio
[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (02): : 300 - 300
[2] Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531-534
Tan, Wei Shen
O'Donnell, Michael
Li, Roger
Kamat, Ashish M.
Packiam, Vignesh T.
[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (01): : 164 - 165
[3] Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean FP Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer
Lestingi, Jean F. P.
Quoc-Dien Trinh
Coelho, Rafael F.
Pontes, Jose, Jr.
Bastos, Diogo A.
Nahas, William C.
[J]. EUROPEAN UROLOGY, 2021, 79 (06) : E184 - E185

← 1 →